Somayeh Hosseinpour-Niazi1, Bahar Bakhshi1, Asiyeh-Sadat Zahedi2, Mahdi Akbarzadeh2, Maryam S Daneshpour3, Parvin Mirmiran4, Fereidoun Azizi5. 1. Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2. Cellular and Molecular Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, No 24, A'rabi St, Yeman Av, P.O. Box 19395-4763, Velenjak, Tehran, Iran. 3. Cellular and Molecular Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, No 24, A'rabi St, Yeman Av, P.O. Box 19395-4763, Velenjak, Tehran, Iran. daneshpour1388@gmail.com. 4. Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, No 24, A'rabi St, Yeman Av, P.O. Box 19395-4763, Velenjak, Tehran, Iran. mirmiran@endocrine.ac.ir. 5. Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract
BACKGROUND: The aim of this study was to investigate whether two variants of the TCF7L2 (rs7903146 and rs12255372) modify the association between nut consumption and the risk of metabolic syndrome (MetS). Additionally, the modifying effect of weight change during follow-up on these associations was investigated. MATERIAL AND METHODS: We prospectively studied 1423 participants of the Tehran Lipid and Glucose study aged 19-74 years who were followed-up for dietary assessment using a validated, semi-quantitative food frequency questionnaire. Multivariable-adjusted Cox regression was used to estimate hazard ratios (HRs) for MetS events. Genotyping was performed by Human Omni Express-24-v1-0 chip. RESULTS: Over a median 8.9 years of follow-up, 415 new cases of MetS were documented. The median nut consumption was 20.0 g/week (Interquartile Range (IQR): 8.6-38.9 g/week). Regarding the rs7903146 genotype, in carriers of T allele (CT + TT), highest tertile of nut consumption was associated with a reduced risk of MetS after adjusting for confounders (HR: 0.67 (0.50-0.91)). Regarding the rs12255372 genotype, highest versus lowest tertile of nut consumption in participants with T allele (GT + TT) resulted in 34% reduction of MetS risk after adjustment for confounders (HR: 0.66 (0.49-0.69)). After stratification by weigh change (< 7% or ≥ 7% weight gain), in individuals with ≥ 7% weight gain, highest tertile of nut consumption was associated with reduced risk of MetS among the risk allele of rs7903146. In the risk allele of rs12255372, among individuals with < 7% weight gain, third tertile of nuts intake reduced the risk of MetS, after adjustment for confounders. CONCLUSION: Higher consumption of nuts may reduces the risk of MetS in T-risk allele of the TCF7L2 rs7903146 and rs12255372 variants and weight change may modify this association.
BACKGROUND: The aim of this study was to investigate whether two variants of the TCF7L2 (rs7903146 and rs12255372) modify the association between nut consumption and the risk of metabolic syndrome (MetS). Additionally, the modifying effect of weight change during follow-up on these associations was investigated. MATERIAL AND METHODS: We prospectively studied 1423 participants of the Tehran Lipid and Glucose study aged 19-74 years who were followed-up for dietary assessment using a validated, semi-quantitative food frequency questionnaire. Multivariable-adjusted Cox regression was used to estimate hazard ratios (HRs) for MetS events. Genotyping was performed by Human Omni Express-24-v1-0 chip. RESULTS: Over a median 8.9 years of follow-up, 415 new cases of MetS were documented. The median nut consumption was 20.0 g/week (Interquartile Range (IQR): 8.6-38.9 g/week). Regarding the rs7903146 genotype, in carriers of T allele (CT + TT), highest tertile of nut consumption was associated with a reduced risk of MetS after adjusting for confounders (HR: 0.67 (0.50-0.91)). Regarding the rs12255372 genotype, highest versus lowest tertile of nut consumption in participants with T allele (GT + TT) resulted in 34% reduction of MetS risk after adjustment for confounders (HR: 0.66 (0.49-0.69)). After stratification by weigh change (< 7% or ≥ 7% weight gain), in individuals with ≥ 7% weight gain, highest tertile of nut consumption was associated with reduced risk of MetS among the risk allele of rs7903146. In the risk allele of rs12255372, among individuals with < 7% weight gain, third tertile of nuts intake reduced the risk of MetS, after adjustment for confounders. CONCLUSION: Higher consumption of nuts may reduces the risk of MetS in T-risk allele of the TCF7L2rs7903146 and rs12255372 variants and weight change may modify this association.
Authors: Pablo Perez-Martinez; Catherine M Phillips; Javier Delgado-Lista; Antonio Garcia-Rios; Jose Lopez-Miranda; Francisco Perez-Jimenez Journal: Curr Vasc Pharmacol Date: 2013-11 Impact factor: 2.719
Authors: Jose C Florez; Kathleen A Jablonski; Nick Bayley; Toni I Pollin; Paul I W de Bakker; Alan R Shuldiner; William C Knowler; David M Nathan; David Altshuler Journal: N Engl J Med Date: 2006-07-20 Impact factor: 91.245
Authors: K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith Journal: Circulation Date: 2009-10-05 Impact factor: 29.690
Authors: Katrine Grau; Stephane Cauchi; Claus Holst; Arne Astrup; J Alfredo Martinez; Wim H M Saris; Ellen E Blaak; Jean-Michel Oppert; Peter Arner; Stephan Rössner; Ian A Macdonald; Eva Klimcakova; Dominique Langin; Oluf Pedersen; Philippe Froguel; Thorkild I A Sørensen Journal: Am J Clin Nutr Date: 2009-12-23 Impact factor: 7.045
Authors: G Hindy; E Sonestedt; U Ericson; X-J Jing; Y Zhou; O Hansson; E Renström; E Wirfält; M Orho-Melander Journal: Diabetologia Date: 2012-07-11 Impact factor: 10.122